Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liisa Harjama

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Dermatologic Therapy|July 5, 2020
Nivolumab-associated pemphigoid-like blistering dermatosis after sun exposureNicolas Kluger, Liisa Harjama, Timo Makkonen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 3, 2025
SERPINB8-associated peeling skin with palmoplantar keratoderma-A new variant and phenotypic expansionEveliina Brandt, Kaisa Kettunen, Outi Elomaa, et al.
American Journal of Medical Genetics. Part A|October 11, 2025
The HRAS Variant c.175G>A (p.Ala59Thr) Causes a Predominantly Ectodermal Phenotype Lacking Classic Costello Syndrome FeaturesNikole Rautiainen, Eveliina Brandt, Kaisa Kettunen, et al.
Frontiers in Cardiovascular Medicine|April 3, 2023
<i>DSP</i> c.6310delA p.(Thr2104Glnfs*12) associates with arrhythmogenic cardiomyopathy, increased trabeculation, curly hair, and palmoplantar keratodermaKrista Heliö, Eveliina Brandt, Satu Vaara, et al.
Clinical and Experimental Dermatology|October 18, 2025
Desmoplakin-associated palmoplantar epidermal differentiation disorder: a distinct phenotype and red flag for cardiomyopathyEveliina Brandt, Krista Heliö, Liisa Harjama, et al.
Acta Dermato-Venereologica|January 17, 2020
Phenotypic Variability with SLURP1 Mutations and Diffuse Palmoplantar KeratodermaLiisa Harjama, Kaisa Kettunen, Outi Elomaa, et al.
Journal of the American Academy of Dermatology|November 11, 2019
Nagashima-type palmoplantar keratosis in Finland caused by a SERPINB7 founder mutationKatariina Hannula-Jouppi, Liisa Harjama, Elisabet Einarsdottir, et al.
Acta Oncologica (Stockholm, Sweden)|March 12, 2015
Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective studyLiisa Harjama, Hanne Kuitunen, Taina Turpeenniemi-Hujanen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Dermatologic Therapy|July 5, 2020
Nivolumab-associated pemphigoid-like blistering dermatosis after sun exposureNicolas Kluger, Liisa Harjama, Timo Makkonen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 3, 2025
SERPINB8-associated peeling skin with palmoplantar keratoderma-A new variant and phenotypic expansionEveliina Brandt, Kaisa Kettunen, Outi Elomaa, et al.
American Journal of Medical Genetics. Part A|October 11, 2025
The HRAS Variant c.175G>A (p.Ala59Thr) Causes a Predominantly Ectodermal Phenotype Lacking Classic Costello Syndrome FeaturesNikole Rautiainen, Eveliina Brandt, Kaisa Kettunen, et al.
Frontiers in Cardiovascular Medicine|April 3, 2023
<i>DSP</i> c.6310delA p.(Thr2104Glnfs*12) associates with arrhythmogenic cardiomyopathy, increased trabeculation, curly hair, and palmoplantar keratodermaKrista Heliö, Eveliina Brandt, Satu Vaara, et al.
Clinical and Experimental Dermatology|October 18, 2025
Desmoplakin-associated palmoplantar epidermal differentiation disorder: a distinct phenotype and red flag for cardiomyopathyEveliina Brandt, Krista Heliö, Liisa Harjama, et al.
Acta Dermato-Venereologica|January 17, 2020
Phenotypic Variability with SLURP1 Mutations and Diffuse Palmoplantar KeratodermaLiisa Harjama, Kaisa Kettunen, Outi Elomaa, et al.
Journal of the American Academy of Dermatology|November 11, 2019
Nagashima-type palmoplantar keratosis in Finland caused by a SERPINB7 founder mutationKatariina Hannula-Jouppi, Liisa Harjama, Elisabet Einarsdottir, et al.
Acta Oncologica (Stockholm, Sweden)|March 12, 2015
Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective studyLiisa Harjama, Hanne Kuitunen, Taina Turpeenniemi-Hujanen, et al.
Pageof 1